(19)
(11) EP 0 646 128 A1

(12)

(43) Date of publication:
05.04.1995 Bulletin 1995/14

(21) Application number: 93909505.0

(22) Date of filing: 14.04.1993
(51) International Patent Classification (IPC): 
A61K 38/ 28( . )
A61K 38/ 26( . )
C07K 1/ 113( . )
C07K 14/ 605( . )
A61K 38/ 04( . )
A61P 3/ 08( . )
C07K 14/ 575( . )
A61K 38/ 00( . )
(86) International application number:
PCT/US1993/003388
(87) International publication number:
WO 1993/025579 (23.12.1993 Gazette 1993/30)
(84) Designated Contracting States:
AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE

(30) Priority: 15.06.1992 US 19920899073

(60) Divisional application:
99110184.1 / 0969016

(71) Applicant: PFIZER INC.
New York, N.Y. 10017 (US)

(72) Inventors:
  • ANDREWS, Glenn, C.
    Waterford, CT 06385 (US)
  • DAUMY, Gaston, O.
    Gales Ferry, CT 06335 (US)
  • FRANCOEUR, Michael, L.
    Hillsborough, CA 94010 (US)
  • LARSON, Eric, R.
    Mystic, CT 06355 (US)

(74) Representative: Ruddock, Keith Stephen 
Pfizer Limited, European Patent Department, Ramsgate Road
Sandwich, Kent CT13 9NJ
Sandwich, Kent CT13 9NJ (GB)

   


(54) GLUCAGON-LIKE PEPTIDE AND INSULINOTROPIN DERIVATIVES